Cytokinetics (CYTK) Stock Price, News, Quotes-Moomoo

US Stock MarketDetailed Quotes

CYTK Cytokinetics

Watchlist

50.660
-0.850-1.65%

Trading Dec 4 14:07 ET

5.98BMarket Cap-9416P/E (TTM)

Intraday

5D
Daily
Weekly
Monthly
1Q
1Y

Trade Overview

Unit: --

Capital Trend

IntradayDayWeekMonth

No Data

News

Cytokinetics Initiates Confirmatory Study on Heart Failure Drug
Zacks 12:05 ET
Cytokinetics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
GlobeNewswireDec 3 16:00 ET
Express News | Cytokinetics Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
ReutersDec 3 16:00 ET
Sector Update: Health Care Stocks Mixed Late Afternoon
MT NewswiresDec 3 15:41 ET
FDA Accepts Cytokinetics' Application for Cardiovascular Drug
Zacks Dec 3 13:00 ET
A Quick Look at Today's Ratings for Cytokinetics(CYTK.US), With a Forecast Between $62 to $120
Moomoo NewsDec 3 08:00 ET · Ratings

Comments

Sean Parker

Nov 19 02:56

$Cytokinetics (CYTK.US)$
Cytokinetics (CYTK) and Bayer have established an exclusive licensing agreement for aficamten in Japan, focusing on treating hypertrophic cardiomyopathy (HCM). The deal includes an upfront payment of €50 million to Cytokinetics, with potential additional earnings of €90 million in milestones through commercial launch (including €20 million near-term) and up to €490 million in commercial milestone payments. The collaboration involves tiered royalties on Japanese sales and ...

Mr Long Term

Aug 13 17:42

Columns Top Calls on Wall Street: Starbucks, Dell, Warner Bros. and More.

Top 5 Upgrades:
Baird upgraded Starbucks $Starbucks (SBUX.US)$ to Outperform from Neutral with a price target of $110, up from $81. The firm sees a more favorable risk/reward on Starbucks shares following the hiring of Brian Niccol as CEO.
Barclays upgraded Dell Technologies $Dell Technologies (DELL.US)$ to Equal Weight from Underweight with an unchanged price target of $97. The firm says much of the artificial intelligence "hype" ...